Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04581304 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 16, 2023 to Dec 17, 2026v3 Show 6 more changesShow less
    • Primary endpoint revised
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 30 to confirmed 36
    • Study completion date: Feb 16, 2024 to Jan 17, 2028
    • Secondary endpoints: details revised at 1 of 4 entries
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 16, 2020 to Oct 15, 2020
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess vertical bone height gain with Geistlich Bio-Oss Collagen used in conjunction with simultaneous implant installation in transcrestal approach sinus augmentation.
Trial Details
NCT Number NCT04581304
Lead Sponsor Rambam Health Care Campus
Conditions
(from sponsor)		 Bone Loss, Missing Teeth
Related terms Anodontia, Bone Diseases, Metabolic
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov